News
PACB
1.360
+2.26%
0.030
Cathie Wood’s ARK Investment bought 344K shares of PacBio today
TipRanks · 12h ago
Trump's Cuts to Medical Research Are Hurting These Stocks
Barron‘s · 13h ago
Largest borrow rate increases among liquid names
TipRanks · 1d ago
Pacific Biosciences of California Inc <PACB.OQ> expected to post a loss of 21 cents a share - Earnings Preview
Reuters · 1d ago
Largest borrow rate increases among liquid names
TipRanks · 2d ago
Analysts Offer Insights on Healthcare Companies: Pacific Biosciences (PACB), Immunovant (IMVT) and 4D Molecular Therapeutics (FDMT)
TipRanks · 2d ago
Barclays Keeps Their Hold Rating on Pacific Biosciences (PACB)
TipRanks · 2d ago
Trump Trade: President to impose 25% tariffs on steel, aluminum imports
TipRanks · 2d ago
Weekly Report: what happened at PACB last week (0203-0207)?
Weekly Report · 3d ago
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Might Not Be As Mispriced As It Looks After Plunging 26%
Simply Wall St · 5d ago
Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: Here's Why
NASDAQ · 02/04 23:15
Unusually active option classes on open February 3rd
TipRanks · 02/03 14:40
PacBio appoints David Ruggiero as head of global sales, service
TipRanks · 02/03 14:15
BRIEF-PacBio Announces Appointment of David Ruggiero as Head of Global Sales & Service
Reuters · 02/03 14:05
Press Release: PacBio Announces Appointment of David Ruggiero as Head of Global Sales & Service
Dow Jones · 02/03 14:05
Weekly Report: what happened at PACB last week (0127-0131)?
Weekly Report · 02/03 09:28
Pacific Biosciences Announces Board Changes for Strategic Growth
TipRanks · 01/30 14:28
PacBio appoints Smith to board of directors
TipRanks · 01/30 14:10
Press Release: PacBio Announces Appointment of Chris Smith to Board of Directors
Dow Jones · 01/30 14:05
*PacBio Announces Appointment of Chris Smith to Board of Directors
Dow Jones · 01/30 14:05
More
Webull provides a variety of real-time PACB stock news. You can receive the latest news about Pacific Biosc through multiple platforms. This information may help you make smarter investment decisions.
About PACB
Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding (SBB) short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which accurately detects the nucleotide sequence and epigenetic status of individual DNA molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.